Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Neuroimaging and therapeutics in movement disorders Eckert T; Eidelberg DNeuroRx 2005[Apr]; 2 (2): 361-71In this review, we discuss the role of neuroimaging in assessing treatment options for movement disorders, particularly Parkinson's disease (PD). Imaging methods to assess dopaminergic function have recently been applied in trials of potential neuroprotective agents. Other imaging methods using regional metabolism and/or cerebral perfusion have been recently introduced to quantify the modulation of network activity as an objective marker of the treatment response. Both imaging strategies have provided novel insights into the mechanisms underlying a variety of pharmacological and stereotaxic surgical treatment strategies for PD and other movement disorders.|Animals[MESH]|Brain Chemistry[MESH]|Clinical Trials as Topic[MESH]|Diagnosis, Differential[MESH]|Dopamine/metabolism[MESH]|Humans[MESH]|Magnetic Resonance Imaging[MESH]|Movement Disorders/*diagnosis/diagnostic imaging/metabolism/*therapy[MESH]|Neuroprotective Agents/therapeutic use[MESH]|Parkinson Disease/diagnostic imaging/drug therapy/metabolism[MESH]|Positron-Emission Tomography[MESH] |